av/lipocine--big.svg

NASDAQ:LPCN

Lipocine

  • Stock

USD

Last Close

2.64

06/11 21:00

Market Cap

40.38M

Beta: 0.94

Volume Today

10.22K

Avg: 201.21K

PE Ratio

−1.28

PFCF: −1.78

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.50
-
average payables
666.65K
-
406.67K
39.00%
376.49K
7.42%
421.99K
12.09%
634.67K
50.40%
926.76K
46.02%
1.39M
49.96%
1.44M
3.85%
944.87K
34.53%
998.18K
5.64%
average receivables
72.27K
-
91.74K
26.94%
1.69M
1,743.23%
1.69M
0.01%
27.52K
98.37%
8.46K
69.27%
123.82K
1,364.22%
453.55K
266.30%
329.93K
27.26%
book value per share
35.10
-
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
capex per share
-0.08
-
-0.01
81.35%
-0.06
275.13%
-0.00
-
-0.00
1.92%
-0.00
65.15%
capex to depreciation
-4.08
-
-1.07
73.67%
-1.87
73.84%
-19.98
-
-14.16
29.13%
-0.46
96.76%
capex to operating cash flow
0.00
-
0.00
45.77%
0.00
74.65%
0.00
-
0.01
549.79%
0.00
92.48%
capex to revenue
-0.00
-
-0.27
56,813.30%
0.00
101.73%
cash per share
36.84
-
22.90
37.83%
24.99
9.11%
18.20
27.17%
12.14
33.29%
9.24
23.90%
6.00
35.03%
8.73
45.32%
0.37
95.79%
4.18
1,037.08%
days of inventory on hand
days payables outstanding
7.22
-
14.71
103.71%
11.11
24.45%
19.84
78.49%
37.90
91.06%
57.78
52.45%
59.80
3.50%
61.39
2.66%
25.61
58.29%
days sales outstanding
32.84
-
36.55
11.29%
5.59
-
481.69
8,515.15%
debt to assets
0.49
-
0.36
26.10%
0.22
39.36%
0.04
80.03%
debt to equity
1.09
-
1.14
4.52%
0.36
67.95%
0.05
86.08%
dividend yield
earnings yield
-0.30
-
-0.04
85.91%
-0.28
560.50%
-0.30
7.73%
-0.42
38.09%
-1.30
210.52%
-0.28
78.78%
-0.01
97.34%
-0.02
144.01%
-1.11
6,090.88%
enterprise value
39.48M
-
405.93M
928.06%
61.63M
84.82%
65.77M
6.72%
29.94M
54.48%
7.39M
75.31%
62.11M
740.27%
85.53M
37.71%
595.71M
596.51%
9.93M
98.33%
enterprise value over ebitda
-1.93
-
-22.11
1,047.11%
-3.48
84.25%
-3.10
10.87%
-2.65
14.69%
-0.56
78.73%
-3.47
515.36%
26.62
867.86%
-51.59
293.82%
-0.61
98.82%
ev to operating cash flow
-2.28
-
-26.43
1,058.47%
-3.37
87.25%
-3.94
16.81%
-2.48
37.05%
-0.63
74.44%
-4.06
540.58%
-19.39
377.71%
-49.77
156.71%
-0.63
98.73%
ev to sales
69.95
-
44.80
35.95%
5.30
-
1.19K
22,384.41%
-3.48
100.29%
free cash flow per share
-23.12
-
-7.94
65.66%
-17.08
115.09%
-14.16
17.09%
-9.62
32.08%
-7.66
20.32%
-4.67
39.03%
-0.86
81.50%
-0.14
84.17%
-2.98
2,075.08%
free cash flow yield
-0.26
-
-0.04
86.03%
-0.27
655.75%
-0.24
11.30%
-0.44
79.71%
-1.17
168.84%
-0.20
82.73%
-0.05
74.62%
-0.02
60.59%
-1.07
5,177.88%
graham net net
34.67
-
21.21
38.82%
23.78
12.13%
14.95
37.15%
3.07
79.43%
0.47
84.82%
2.95
531.72%
7.41
151.35%
0.35
95.25%
3.68
946.75%
graham number
146.38
-
67.68
53.76%
98.12
44.97%
80.25
18.21%
39.61
50.65%
28.18
28.86%
25.97
7.83%
4.99
80.80%
1.05
78.95%
16.43
1,464.63%
income quality
0.85
-
0.84
0.71%
0.96
14.26%
0.80
17.40%
1.04
30.14%
0.90
13.42%
0.73
18.61%
6.95
852.61%
1.11
84.00%
0.96
13.87%
intangibles to total assets
0
-
-0.62
Infinity%
0
100%
0
0
0
0
0
0
0
interest coverage
-46.55
-
15.47
133.24%
-447.24
2,990.50%
interest debt per share
8.17
-
4.69
42.53%
1.82
61.14%
0.49
73.06%
0.00
99.94%
inventory turnover
invested capital
1.09
-
1.14
4.52%
0.36
67.95%
0.05
86.08%
market cap
67.15M
-
425.94M
534.30%
67.19M
84.23%
68.98M
2.66%
27.76M
59.76%
9.97M
64.07%
75.74M
659.46%
86.17M
13.77%
598.86M
594.99%
14.70M
97.54%
net current asset value
26.26M
-
41.49M
57.97%
25.88M
37.61%
18.87M
27.08%
9.39M
50.24%
6.26M
33.33%
15.32M
144.68%
39.47M
157.65%
32.23M
18.34%
20.23M
37.23%
net debt to ebitda
1.35
-
1.09
19.31%
0.31
71.17%
0.15
51.78%
-0.19
227.37%
0.20
201.91%
0.76
286.68%
-0.20
126.18%
0.27
236.96%
0.29
7.01%
net income per share
-27.13
-
-9.40
65.36%
-17.66
87.98%
-17.79
0.71%
-9.28
47.82%
-8.54
7.97%
-6.40
25.09%
-0.12
98.06%
-0.12
1.96%
-3.10
2,451.34%
operating cash flow per share
-23.04
-
-7.92
65.61%
-17.02
114.79%
-14.16
16.81%
-9.62
32.08%
-7.66
20.32%
-4.67
39.03%
-0.86
81.53%
-0.14
84.31%
-2.97
2,097.55%
payables turnover
50.54
-
24.81
50.91%
32.84
32.37%
18.40
43.97%
9.63
47.66%
6.32
34.41%
6.10
3.38%
5.95
2.59%
14.25
139.72%
receivables turnover
11.11
-
9.99
10.15%
65.28
-
0.76
98.84%
research and ddevelopement to revenue
15.10
-
45.26
199.70%
474.92
-
17.11
96.40%
-3.57
120.86%
return on tangible assets
-0.73
-
-0.25
66.00%
-0.69
180.39%
-0.83
19.41%
-0.56
32.51%
-0.66
18.33%
-0.83
24.97%
-0.01
98.54%
-0.29
2,270.72%
-0.71
148.08%
revenue per share
0.34
-
0.11
68.20%
3.16
-
0.01
99.82%
-0.54
9,670.83%
roe
-0.77
-
-0.43
43.89%
-0.73
68.14%
-1.11
51.61%
-1.24
11.80%
-2.07
67.37%
-1.37
33.94%
-0.01
98.98%
-0.30
2,068.69%
-0.80
165.90%
roic
-0.78
-
-0.44
43.65%
-0.74
68.45%
-1.12
51.58%
-0.58
48.55%
-0.96
66.95%
-0.86
10.46%
0.07
107.64%
-0.34
617.57%
-0.80
136.03%
sales general and administrative to revenue
12.36
-
33.92
174.53%
0.33
-
8.12
2,360.59%
-1.72
121.18%
shareholders equity per share
35.10
-
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
stock based compensation to revenue
3.41
-
6.28
84.35%
0.04
-
1.27
3,300.25%
-0.23
118.04%
tangible asset value
26.36M
-
70.19M
166.27%
26.02M
62.93%
18.98M
27.05%
9.43M
50.30%
6.29M
33.35%
15.34M
144.00%
45.57M
197.03%
35.63M
21.80%
20.37M
42.84%
tangible book value per share
35.10
-
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
working capital
26.26M
-
41.49M
57.97%
25.88M
37.61%
18.87M
27.08%
16.32M
13.55%
14.67M
10.12%
18.75M
27.81%
40.76M
117.46%
32.46M
20.38%
20.23M
37.67%

All numbers in USD (except ratios and percentages)